JP2024540053A5 - - Google Patents
Info
- Publication number
- JP2024540053A5 JP2024540053A5 JP2024525208A JP2024525208A JP2024540053A5 JP 2024540053 A5 JP2024540053 A5 JP 2024540053A5 JP 2024525208 A JP2024525208 A JP 2024525208A JP 2024525208 A JP2024525208 A JP 2024525208A JP 2024540053 A5 JP2024540053 A5 JP 2024540053A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- subject
- composition according
- week
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163275356P | 2021-11-03 | 2021-11-03 | |
| US63/275,356 | 2021-11-03 | ||
| PCT/US2022/079144 WO2023081704A1 (en) | 2021-11-03 | 2022-11-02 | Methods of treating cancers and enhancing efficacy of gprc5dxcd3 bispecific antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540053A JP2024540053A (ja) | 2024-10-31 |
| JP2024540053A5 true JP2024540053A5 (https=) | 2025-11-12 |
Family
ID=86242157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525208A Pending JP2024540053A (ja) | 2021-11-03 | 2022-11-02 | 癌を治療する方法及びｇｐｒｃ５ｄｘｃｄ３二重特異性抗体の有効性を向上させる方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230295292A1 (https=) |
| EP (1) | EP4426436A4 (https=) |
| JP (1) | JP2024540053A (https=) |
| KR (1) | KR20240099371A (https=) |
| CN (1) | CN118369114A (https=) |
| AU (1) | AU2022382978A1 (https=) |
| CA (1) | CA3237352A1 (https=) |
| IL (1) | IL312513A (https=) |
| MX (1) | MX2024005391A (https=) |
| WO (1) | WO2023081704A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA130542C2 (uk) * | 2018-05-16 | 2026-03-18 | Янссен Байотек, Інк. | Антитіло до cd38 та терапевтичний засіб, який перенаправляє т-клітини, для лікування множинної мієломи у суб'єкта |
| WO2021050527A1 (en) * | 2019-09-09 | 2021-03-18 | The Regents Of The University Of California | Compositions and methods for making and using multispecific antibodies |
| US20230128499A1 (en) * | 2020-03-27 | 2023-04-27 | Novartis Ag | Bispecific combination therapy for treating proliferative diseases and autoimmune diseases |
-
2022
- 2022-11-02 EP EP22891007.1A patent/EP4426436A4/en active Pending
- 2022-11-02 AU AU2022382978A patent/AU2022382978A1/en active Pending
- 2022-11-02 KR KR1020247018007A patent/KR20240099371A/ko active Pending
- 2022-11-02 WO PCT/US2022/079144 patent/WO2023081704A1/en not_active Ceased
- 2022-11-02 US US18/052,172 patent/US20230295292A1/en active Pending
- 2022-11-02 JP JP2024525208A patent/JP2024540053A/ja active Pending
- 2022-11-02 CA CA3237352A patent/CA3237352A1/en active Pending
- 2022-11-02 CN CN202280073849.4A patent/CN118369114A/zh active Pending
- 2022-11-02 MX MX2024005391A patent/MX2024005391A/es unknown
- 2022-11-02 IL IL312513A patent/IL312513A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540054A5 (https=) | ||
| JP2022185004A5 (https=) | ||
| US11591406B2 (en) | Treatment for multiple myeloma (MM) | |
| JP2023544407A5 (https=) | ||
| JP2019502676A5 (https=) | ||
| JP2018520101A5 (https=) | ||
| IL312503A (en) | Methods of treating cancers and enhancing efficacy of bcmaxcd3 bispecific antibodies | |
| JP2021512107A5 (https=) | ||
| JP2023542124A5 (https=) | ||
| JP2018506550A5 (https=) | ||
| JP2021535758A5 (https=) | ||
| JP2017534646A5 (https=) | ||
| JP2023505217A5 (https=) | ||
| JP2023520771A5 (https=) | ||
| JP2024534602A5 (https=) | ||
| JP2024540053A5 (https=) | ||
| JP2022513029A5 (https=) | ||
| JP2024509332A5 (https=) | ||
| JP2024522620A5 (https=) | ||
| RU2026104179A (ru) | Способы лечения множественной миеломы | |
| RU2025131684A (ru) | Способы лечения множественной миеломы | |
| JP2022537134A5 (https=) | ||
| RU2025138318A (ru) | Способы лечения множественной миеломы | |
| JP2025508832A5 (https=) | ||
| NZ769968B2 (en) | Bcma/cd3 and gprdc5d/cd3 bispecific antibodies for use in cancer therapy |